Rhythm Pharmaceuticals (RYTM) Times Interest Earned (2022 - 2025)
Historic Times Interest Earned for Rhythm Pharmaceuticals (RYTM) over the last 4 years, with Q3 2025 value amounting to -$11.1.
- Rhythm Pharmaceuticals' Times Interest Earned fell 3263.02% to -$11.1 in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.7, marking a year-over-year increase of 3728.67%. This contributed to the annual value of -$12.89 for FY2024, which is 289.44% up from last year.
- Latest data reveals that Rhythm Pharmaceuticals reported Times Interest Earned of -$11.1 as of Q3 2025, which was down 3263.02% from -$7.79 recorded in Q2 2025.
- Rhythm Pharmaceuticals' 5-year Times Interest Earned high stood at -$7.57 for Q4 2024, and its period low was -$980.35 during Q2 2022.
- Its 4-year average for Times Interest Earned is -$82.05, with a median of -$12.53 in 2023.
- Its Times Interest Earned has fluctuated over the past 5 years, first surged by 9856.08% in 2023, then plummeted by 7142.51% in 2024.
- Rhythm Pharmaceuticals' Times Interest Earned (Quarter) stood at -$13.98 in 2022, then surged by 35.14% to -$9.07 in 2023, then grew by 16.49% to -$7.57 in 2024, then tumbled by 46.6% to -$11.1 in 2025.
- Its Times Interest Earned stands at -$11.1 for Q3 2025, versus -$7.79 for Q2 2025 and -$8.69 for Q1 2025.